FR16C0033I1 - - Google Patents

Info

Publication number
FR16C0033I1
FR16C0033I1 FR16C0033C FR16C0033I1 FR 16C0033 I1 FR16C0033 I1 FR 16C0033I1 FR 16C0033 C FR16C0033 C FR 16C0033C FR 16C0033 I1 FR16C0033 I1 FR 16C0033I1
Authority
FR
France
Prior art keywords
hydroxypyrone
iron
reacting
carboxylic acid
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of FR16C0033I1 publication Critical patent/FR16C0033I1/fr
Application granted granted Critical
Publication of FR16C0033I2 publication Critical patent/FR16C0033I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Iron (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A method of forming an iron hydroxypyrone compound comprising reacting an iron salt of a carboxylic acid and a hydroxypyrone in an aqueous solution at a pH greater than 7.
FR16C0033C 2002-05-18 2016-08-09 METHOD OF FORMATION OF IRON HYDROXYPYRONE COMPOUNDS Active FR16C0033I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0211500.4A GB0211500D0 (en) 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds
PCT/GB2003/001956 WO2003097627A1 (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds

Publications (2)

Publication Number Publication Date
FR16C0033I1 true FR16C0033I1 (en) 2016-09-23
FR16C0033I2 FR16C0033I2 (en) 2018-01-19

Family

ID=9936987

Family Applications (1)

Application Number Title Priority Date Filing Date
FR16C0033C Active FR16C0033I2 (en) 2002-05-18 2016-08-09 METHOD OF FORMATION OF IRON HYDROXYPYRONE COMPOUNDS

Country Status (11)

Country Link
US (1) US7459569B2 (en)
EP (1) EP1506183B1 (en)
AT (1) ATE352547T1 (en)
AU (1) AU2003233881A1 (en)
BE (1) BE2016C041I2 (en)
CA (1) CA2483067C (en)
DE (1) DE60311456T2 (en)
ES (1) ES2283771T3 (en)
FR (1) FR16C0033I2 (en)
GB (1) GB0211500D0 (en)
WO (1) WO2003097627A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8952061B2 (en) * 2006-08-22 2015-02-10 University Of Virginia Patent Foundation Methods and compounds regulating the erythroid response to iron deficiency
US8058462B2 (en) 2007-02-06 2011-11-15 Medical Research Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
GB2531742B (en) 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
EA201892194A1 (en) 2016-03-31 2019-04-30 Юнайтед Киндом Рисёрч Энд Инновейшн COMPOSITIONS OF THE COMPLEX OF A THREE VALVE IRON WITH A BALT FOR APPLICATION FOR THE TREATMENT OR PREVENTION OF CANCER AND TUMOR
AU2017242906B2 (en) * 2016-03-31 2020-11-19 Shield TX (UK) Limited Methods for producing Ferric maltol compositions from Ferrous Hydroxides
JP7033546B2 (en) * 2016-03-31 2022-03-10 シールド ティーエックス （ユーケー） リミテッド Methods for Producing Maltol Ferric Compositions from Elemental Iron
JP7033545B2 (en) * 2016-03-31 2022-03-10 シールド ティーエックス （ユーケー） リミテッド Methods for Producing Maltol Ferric Ferric Compositions from Ligand-Modified and Ligand-Coated Ferric Hydroxide
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CN112574158B (en) * 2020-12-29 2022-08-02 南京百泽医药科技有限公司 Maltoferric crystal form II and preparation method thereof
CN115177625A (en) * 2022-06-28 2022-10-14 金陵药业股份有限公司 Carboxyl ferric maltose pharmaceutical composition and preparation method thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130204A (en) 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
FR1500765A (en) 1963-09-19 1967-11-10 Pfizer & Co C Pyromeconic acid derivatives and process for their preparation
SE322866B (en) 1966-12-15 1970-04-20 Astra Ab
US4018907A (en) 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4212685A (en) * 1978-12-11 1980-07-15 Lea Manufacturing Company Protective and color receptive coating for aluminum
US4279936A (en) 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
GR78491B (en) 1982-03-24 1984-09-27 Nat Res Dev
EP0094149B1 (en) 1982-03-24 1986-09-10 National Research Development Corporation Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives
EP0107458B1 (en) 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
GB8308055D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308054D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8410289D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8606913D0 (en) 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
JPH0367565A (en) 1989-08-07 1991-03-22 Kansai Paint Co Ltd Iron-enriched food
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
ES2230564T3 (en) * 1995-06-10 2005-05-01 Vitra Pharmaceuticals Ltd. FERRIC COMPOUNDS, COMPOSITIONS, METHODS OF MANUFACTURE OF THESE AND ITS USED.
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method

Also Published As

Publication number Publication date
FR16C0033I2 (en) 2018-01-19
DE60311456T2 (en) 2007-11-15
US20050250754A1 (en) 2005-11-10
CA2483067C (en) 2011-04-26
WO2003097627A1 (en) 2003-11-27
EP1506183A1 (en) 2005-02-16
US7459569B2 (en) 2008-12-02
GB0211500D0 (en) 2002-06-26
EP1506183B1 (en) 2007-01-24
DE60311456D1 (en) 2007-03-15
ES2283771T3 (en) 2007-11-01
ATE352547T1 (en) 2007-02-15
AU2003233881A1 (en) 2003-12-02
BE2016C041I2 (en) 2022-08-09
CA2483067A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
BE2016C041I2 (en)
EP2272825A3 (en) N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation
MXPA03009565A (en) Carboxylic acid derivative and salt thereof.
ZA200308319B (en) Method for producing an aqueous acrylamide solution with a biocatalyst.
MXPA01002392A (en) Methods and acidizing compositions for reducing metal surface corrosion and sulfide precipitation.
CA2457584A1 (en) Enhancing solubility of iron amino acid chelates and iron proteinates
YU2003A (en) Stable salts of o-acetylsalicyclic acid with basic amino acids
AU3309995A (en) Water soluble cyclic amine-dicarboxylic acid-alkanol amine salt corrosion inhibitor
WO2003088956A8 (en) Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
WO2003062344A3 (en) Acidizing and scale treatment of subterranean formation
EP1767521A4 (en) L-ornithine-citric acid salt crystal
RS50685B (en) Concentrated aqueous solution of ambroxol
IL157495A0 (en) Method for the production of d-panthothenic acid and/or salts thereof as adjunct for animal feedstuffs
AU2002308031A1 (en) Enteric ketoacid salts and amino acids
WO2004095921A3 (en) Sporicidal composition
NZ334940A (en) process of producing 4-(des-dimethylamino)-tetracycline
IN2003CH01298A (en) Method for producing D-pantothenic acid and/or salt thereof as additive for animal feesdstuffs
IL157402A0 (en) Method for producing d-pantothenic acid and/or salts therefor as an additive for animal feed
IN2003CH01315A (en) Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed
BG102347A (en) New carboxylic acid derivatives, method for their preparation and application
AU2001249606A1 (en) Method of cyanide salt production
GB2382573B (en) Dissolution method of co precipitate with acid
MY134147A (en) Method for stoping hysteresis
BG105780A (en) Method for producing derivatives of biphenyl-2-carboxylic acid
MXPA04000513A (en) Method for preparing 4-methylamino-4-phenylpiperidine.